Summary:
We are conducting a 52-week study (with the possibility of a + 1 year extension to the study) for patients who have been diagnosed with Benign Prostatic Hyperplasia (BPH). If you are interested in taking pills, or if pills do not seem to work, you may be interested in this Phase 3 clinical drug trial.
Qualified Participants Must:
• Be male 45 years of age or older
•
Have been diagnosed with BPH for 1 year or longer
•
Be willing to discontinue all BPH medications prior to participation
Qualified Participants May Receive:
Qualified participants will receive study medication, study related physical exams, laboratories, ekg’s, (at no cost), and compensations for time and travel.